PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Neurocritical Care10.18700/jnc.1800662018112137-142Consciousness Recovery by Rituximab after Seizure Control in Cryptogenic New-Onset Refractory Status EpilepticusTae-Won Yang, Jeong Won Jo, Do-Hyung Kim, Young-Soo Kim, Oh-Young Kwonhttp://e-jnc.org/upload/pdf/jnc-180066.pdf, http://e-jnc.org/journal/view.php?doi=10.18700/jnc.180066, http://e-jnc.org/upload/pdf/jnc-180066.pdf
Seizure10.1016/j.seizure.2012.09.011201322170-73Plasma exchange in cryptogenic new onset refractory status epilepticusJudy Li, Christina Saldivar, Rama K. Magantihttps://api.elsevier.com/content/article/PII:S1059131112002531?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131112002531?httpAccept=text/plain
Seizure10.1016/j.seizure.2018.09.01820196872-78New onset refractory status epilepticus (NORSE)Claudine Sculier, Nicolas Gaspardhttps://api.elsevier.com/content/article/PII:S1059131118301924?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131118301924?httpAccept=text/plain
Seizure10.1016/j.seizure.2020.01.022202076131-136Is rat hippocampus section immunostaining an indicator for immunotherapy in cryptogenic adult new-onset refractory status epilepticus (NORSE)?Dongmei Wang, Yue Pan, Kaibin Huang, Zhenzhou Lin, Zuoshan Xie, Guanghui Liu, Yongming Wu, Shengnan Wanghttps://api.elsevier.com/content/article/PII:S1059131120300418?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131120300418?httpAccept=text/plain
Seizure10.1016/j.seizure.2021.11.020202294126-128High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE)Seyhmus Aydemir, Padmaja Kandulahttps://api.elsevier.com/content/article/PII:S1059131121003770?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131121003770?httpAccept=text/plain
Seizure10.1016/j.seizure.2021.09.01820219395-101Histopathology of new-onset refractory status epilepticus (NORSE) in adultsKushak Suchdev, William J. Kupsky, Sandeep Mittal, Aashit K. Shahhttps://api.elsevier.com/content/article/PII:S1059131121003162?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131121003162?httpAccept=text/plain
Seizure10.1016/j.seizure.2019.12.00220207441-48New-onset refractory status epilepticus: A retrospective cohort studyJames J. Gugger, Khalil Husari, John C. Probasco, Mackenzie C. Cervenkahttps://api.elsevier.com/content/article/PII:S1059131119306016?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131119306016?httpAccept=text/plain
Seizure10.1016/j.seizure.2012.12.0162013223217-220Five cases of new onset refractory status epilepticus (NORSE) syndrome: Outcomes with early immunotherapyClaire R.E. Gall, Odai Jumma, Rajiv Mohanrajhttps://api.elsevier.com/content/article/PII:S105913111200338X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S105913111200338X?httpAccept=text/plain
Seizure10.1016/j.seizure.2019.10.005202075174-184New-onset super refractory status epilepticus: A case-seriesSidra Aurangzeb, Lara Prisco, Jane Adcock, Mahiri Speirs, Simon Raby, Jon Westbrook, Arjune Senhttps://api.elsevier.com/content/article/PII:S1059131119302766?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131119302766?httpAccept=text/plain
Seizure10.1016/j.seizure.2020.08.007202081166Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”Alessandro Dinoto, Marta Cheli, Arianna Sartori, Paolo Manganottihttps://api.elsevier.com/content/article/PII:S1059131120302430?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1059131120302430?httpAccept=text/plain